457 related articles for article (PubMed ID: 17641842)
1. Re-expression of RASSF1A by 5-Aza-CdR induced demethylation of the promoter region in human biliary tract carcinoma cells.
Zuo S; Chen Y; Xu L; Tang Q; Zou S
J Huazhong Univ Sci Technolog Med Sci; 2007 Jun; 27(3):281-4. PubMed ID: 17641842
[TBL] [Abstract][Full Text] [Related]
2. Study of 5-Aza-CdR on transcription regulation of RASSF1A gene in the BIU87 cell line.
Liu X; Dai X; Wu B
Urol Int; 2009; 82(1):108-12. PubMed ID: 19172108
[TBL] [Abstract][Full Text] [Related]
3. Regulation of demethylation and re-expression of RASSF1A gene in gastric cancer cell lines by combined treatment of 5-Aza-CdR and NaB.
Shen WJ; Dai DQ; Teng Y; Liu HB
World J Gastroenterol; 2008 Jan; 14(4):595-600. PubMed ID: 18203293
[TBL] [Abstract][Full Text] [Related]
4. [The Role of 5-Aza-CdR on Methylation of Promoter in RASSF1A Gene in Endometrial Carcinoma].
Huang LP; Chen C; Wang XP; Liu H
Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 May; 46(3):380-3. PubMed ID: 26121857
[TBL] [Abstract][Full Text] [Related]
5. Emodin enhances the demethylation by 5-Aza-CdR of pancreatic cancer cell tumor-suppressor genes P16, RASSF1A and ppENK.
Pan FP; Zhou HK; Bu HQ; Chen ZQ; Zhang H; Xu LP; Tang J; Yu QJ; Chu YQ; Pan J; Fei Y; Lin SZ; Liu DL; Chen L
Oncol Rep; 2016 Apr; 35(4):1941-9. PubMed ID: 26782786
[TBL] [Abstract][Full Text] [Related]
6. [5-Aza-CdR regulates the expression of RASSF1A gene in human gastric cancer cell line and inhibits the growth of cells].
Shen WJ; Dai DQ; Teng Y; Liu HB
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Jan; 12(1):57-60. PubMed ID: 19145506
[TBL] [Abstract][Full Text] [Related]
7. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
Li Z; Zhang H; Yang J; Hao T; Li S
Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295
[TBL] [Abstract][Full Text] [Related]
8. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.
Koutsimpelas D; Pongsapich W; Heinrich U; Mann S; Mann WJ; Brieger J
Oncol Rep; 2012 Apr; 27(4):1135-41. PubMed ID: 22246327
[TBL] [Abstract][Full Text] [Related]
9. [Effects and mechanisms of 5-aza-2'-deoxycytidine on endometrial cancer cell.].
Zhang YQ; Mao XY; Ma XL; Zhang M; Sheng N
Zhonghua Fu Chan Ke Za Zhi; 2009 Nov; 44(11):861-4. PubMed ID: 20079041
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic inactivation of RASSF1A in head and neck cancer.
Dong SM; Sun DI; Benoit NE; Kuzmin I; Lerman MI; Sidransky D
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3635-40. PubMed ID: 14506151
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells.
Zhu WG; Dai Z; Ding H; Srinivasan K; Hall J; Duan W; Villalona-Calero MA; Plass C; Otterson GA
Oncogene; 2001 Nov; 20(53):7787-96. PubMed ID: 11753657
[TBL] [Abstract][Full Text] [Related]
12. 5-Aza-CdR can reverse gefitinib resistance caused by DAPK gene promoter methylation in lung adenocarcinoma cells.
Yang B; Yang ZG; Gao B; Shao GG; Li GH
Int J Clin Exp Pathol; 2015; 8(10):12961-6. PubMed ID: 26722491
[TBL] [Abstract][Full Text] [Related]
13. [Growth and gene expression of leukemia cell after treated with methylation inhibitor 5-aza-2'-deoxycytidine].
Qiao SK; Xu SR; Guo XN
Zhonghua Xue Ye Xue Za Zhi; 2004 Aug; 25(8):486-90. PubMed ID: 15555266
[TBL] [Abstract][Full Text] [Related]
14. [The Study of Decitabine Effect on the Endometrial Carcinoma Xenografted in Nude Mice.].
Li RH; Wang XP; Liu H
Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 47(6):843-847. PubMed ID: 28598109
[TBL] [Abstract][Full Text] [Related]
15. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
[TBL] [Abstract][Full Text] [Related]
16. [Study of RASSF1A expression and promoter demethylation in Hep-2 cell line].
Yang J; Ji W; Qu Y; He L; Zhao X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Jan; 25(2):64-6. PubMed ID: 21473137
[TBL] [Abstract][Full Text] [Related]
17. A novel mechanism for acquired cisplatin-resistance: suppressed translation of death-associated protein kinase mRNA is insensitive to 5-aza-2'-deoxycitidine and trichostatin in cisplatin-resistant cervical squamous cancer cells.
Bai T; Tanaka T; Yukawa K; Umesaki N
Int J Oncol; 2006 Feb; 28(2):497-508. PubMed ID: 16391806
[TBL] [Abstract][Full Text] [Related]
18. Effect of methylation-associated silencing of the death-associated protein kinase gene on nasopharyngeal carcinoma.
Kong WJ; Zhang S; Guo CK; Wang YJ; Chen X; Zhang SL; Zhang D; Liu Z; Kong W
Anticancer Drugs; 2006 Mar; 17(3):251-9. PubMed ID: 16520653
[TBL] [Abstract][Full Text] [Related]
19. [Synergistic effect of DNA methylation inhibitor and histone deacetylase inhibitor on RASSF1A gene expression in U266 cells.].
Lu F; Liu CF; Ma DX; Liu YP; Kong HL; Zhang JJ
Zhonghua Xue Ye Xue Za Zhi; 2010 Apr; 31(4):223-7. PubMed ID: 20510036
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of retinoblastoma protein-interacting zinc-finger gene 1 in human esophageal squamous cell cancer by DNA methylation.
Dong SW; Cui YT; Zhong RR; Liang DC; Liu YM; Wang YG; He Z; Wang S; Liang SJ; Zhang P
Clin Lab; 2012; 58(1-2):41-51. PubMed ID: 22372344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]